MedPath
NMPA Approval

Vi Polysaccharide Typhoid Vaccine

国药准字S10960013

November 18, 2020

国药准字S10960013

Drug Information

伤寒Vi多糖疫苗

注射剂(注射液)

每支1ml(2次人用剂量)。每1次人用剂量0.5ml,含伤寒Vi多糖应不低于30μg。

生物制品

November 18, 2020

Company Information

Applicant Company

四川省成都市锦江区锦华路三段379号

Manufacturing Company

四川省成都市锦江区锦华路三段379号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

伤寒Vi多糖疫苗 - NMPA 批准文号 | MedPath